Windlas Biotech IPO opens at the novel time: Here’s all the pieces it is crucial to know

By: Bid Web Desk | New Delhi |

August 4, 2021 8: 00: 00 am

Windlas Biotech, Windlas Biotech IPOWindlas Biotech IPO comes with a stamp band of Rs 448-460 per share. (Image: Windlas Biotech)

Windlas Biotech IPO: The preliminary public providing (IPO) of Windlas Biotech, a producer of pharmaceutical formulations, will delivery for subscription on Wednesday, August 4, 2021, at a stamp band of Rs 448-460 per share of the face charge of Rs 5 each and each. The provide shall be on hand till Friday, August 6, 2021.

The firm plans to elevate Rs 401.53 crore with the help of novel issuance of equity shares charge Rs 165 crore and a proposal within the marketplace (OFS) of as a lot as 51,42,067 equity shares. Below the OFS, Vimla Windlass will offload 11.36 lakh equity shares and investor Tano India Internal most Fairness Fund II will sell 40,06,067 equity shares.

Half of the peril dimension has been reserved for qualified institutional investors (QIBs), 35 per cent for retail investors and the leisure 15 per cent for non institutional investors.

The proceeds from the IPO shall be utilised for procuring of equipment required for capacity growth of the means at Dehradun Plant -IV and addition of injectables dosage capacity at the means at Dehradun Plant-II.

Investors who must subscribe to the Windlas Biotech IPO can remark in moderately lots of 30 equity shares and multiples thereafter. On the upper stamp band, they'll be meting out Rs 13,800 to get a single lot of Windlas Biotech. The shares shall be listed on each and each BSE as well as the Nationwide Stock Alternate (NSE).

The candidates also must repeat that the lower-off time for UPI mandate confirmation is Monday, August 9, 2021, upto 12: 00 pm. In the event that they fail to retain out so then their software program would possibly well perhaps fair no longer be view to be.

SBI Capital Markets, DAM Capital Advisors and IIFL Securities are the book working lead managers to the IPO while Hyperlink Intime India is the registrar of the peril.

Earlier than heading into the IPO, Windlas Biotech raised over Rs 120.46 crore (Rs 1,20,46,04,760) from 22 anchor investors in lieu of 26,18,706 equity shares at Rs 460 each and each, data from the inventory exchanges showed.

The anchor investors consist of the likes of ICICI Prudential Mutual Fund (MF), UTI MF, Sundaram MF, Kuber India Fund, BNP Paribas Arbitrage, Elara India Opportunities Fund and Canara HSBC Oriental Bank of Commerce Existence Insurance Firm among others.

The percentage fragment is at possibility of occur on August 11, 2021, and the shares are expected to be listed on August 17, 2021, in accordance with the timeline given within the crimson herring prospectus (RHP).

📣 The Indian Bid is now on Telegram. Click here to be half of our channel (@indianexpress) and preserve updated with the latest headlines

Read Extra

Website Designed & SEO done by KV TechMedia - Web Design Company Uttar Pradesh, India
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram